Focusing on oncogenic driver mutations and resistance mechanisms in the treatment of NSCLC

  • Post author:
  • Post category:uncategorized

Lung cancer is the leading cause of cancer-related death worldwide. Improved understanding of driver mutations of non-small cell lung cancer (NSCLC) has led to more biomarker-directed treatment for patients with advanced stages.